This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Non Familial Chylocmicronemia Syndrome (Non-FCS)
and you are
over 18
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

This study is to determine a dose response signal for LCQ908 monotherapy and to assess the efficacy and safety of adding LCQ908 to Lovaza or fenofibrate.

Provided treatments

  • Drug: LCQ908
  • Drug: Fenofibrate
  • Drug: Fish Oil
  • Drug: Placebo of LCQ908
  • Drug: Placebo of fenofibrate
  • Drug: Placebo of fish oil

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01594983. The sponsor of the trial is Novartis Pharmaceuticals and it is looking for 58 volunteers for the current phase.
Official trial title:
A Multicenter, Randomized, Active Comparator, Placebo Controlled, Double-blind Pilot Study to Assess the Efficacy and Safety of LCQ908 Alone and in Combination With Fenofibrate or Lovaza® in Patients With Severe Hypertriglyceridemia